文献速递肝病

儿童不明原因急性重型非甲至戊型肝炎——德国西北部30年回顾性观察研究

Acute severe non-A-E-hepatitis of unknown origin in children - A 30-year retrospective observational study from north-west Germany.
PubMed 文献 · J Hepatol · 2022-12-23

该研究分析德国西北部两家医院1990年至2022年5月16日收治的107例儿童急性重型非甲至戊型肝炎,分为历史队列(1990-2018)与COVID-19时代队列(2019-2022)。中心年发病率从2.2例升至4.25例(p=0.002),64.5%符合儿童急性肝衰竭标准,44例需肝移植,19例(17.8%)死亡;当前队列临床表现类似2022年病例且结局优于历史对照。

要点

  • 儿童急性重型非甲至戊型肝炎罕见但严重,常导致急性肝衰竭。
  • 中心年发病率从历史队列2.2例升至2019年后4.25例(p=0.002)。
  • 当前队列中感染、胃肠道症状及较高丙氨酸氨基转移酶与无移植生存相关。

核心结论

  • 儿童急性非甲至戊型肝炎是罕见但严重的疾病,常导致急性肝衰竭。
  • 当前队列临床表现类似2022年非甲至戊型肝炎病例,结局较历史对照改善。
  • 2019年以来中心非甲至戊型肝炎发病率上升且无腺病毒感染,提示其他潜在触发因素。

研究设计与样本

  • 回顾性观察研究,分析汉诺威医学院1990年起及埃森大学医院2009年至2022年5月16日收治的儿童急性重型肝炎病例。
  • 按世界卫生组织定义纳入,分为历史队列(1990-2018)与COVID-19时代队列(2019-2022)。
  • 应用排除标准后共识别107例急性重型肝炎患者(每中心每年2.32例)。

主要发现

  • 中心年发病率从历史队列(至2018年)的2.2例/中心/年显著升至2019年后的4.25例/中心/年(p=0.002)。
  • 75.7%的病例出现黄疸,53.3%有感染临床征象;证实2例腺病毒(2004/2016),其他检出病原体包括HHV-6(4例)、CMV、HSV、EBV(3例)。
  • 69例(64.5%)符合儿童急性肝衰竭标准,其中44例需肝移植。
  • 当前队列中,感染、胃肠道症状及较高丙氨酸氨基转移酶的患者无移植生存机会更好,而肝性脑病、较高国际标准化比值和胆红素预测不良结局。
  • 25例发生肝炎相关再生障碍性贫血,19例(17.8%)死亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The etiology of the current acute severe non-A-E hepatitis epidemic in children remains unclear. We aimed to describe the occurrence and outcomes of acute severe hepatitis in pediatric patients in North-West Germany over a period of more than 30 years and in the context of the current epidemic. METHODS: We analyzed all cases of acute severe hepatitis in childhood, as defined by the World Health Organization, at Hannover Medical School from 1990 and at the University Hospital of Essen from 2009 to 16 May 2022. We separated cases into a historic cohort (1990-2018) and a COVID-19 era cohort (2019-2022). RESULTS: After application of exclusion criteria, 107 patients with acute severe hepatitis were identified (2.32 cases/center/year). Annual incidence per center rose significantly from 2.2 (historic cohort until 2018) to 4.25/center/year (from 2019, p = 0.002). Of all cases, 75.7% presented with jaundice, while 53.3% had clinical signs of infection. Two cases of adenovirus were proven (2004/2016), other pathogens detected were HHV-6 (4), CMV, HSV, EBV(3). Sixty-nine patients (64.5%) met the criteria of pediatric acute liver failure, with 44 requiring liver transplantation. In the current cohort, patients with infection, gastrointestinal symptoms and higher alanine aminotransferase had a better chance of transplant-free survival, whereas hepatic encephalopathy, higher international normalized ratio and bilirubin predicted a poor outcome. Twenty-five patients developed hepatitis-associated aplastic anemia and 19 patients (17.8%) died. CONCLUSIONS: Acute non-A-E-hepatitis in children is a rare but severe entity, often leading to acute liver failure. Clinical presentation in our current cohort resembles 2022 NAEH cases, with improved outcomes compared to historic controls. The rising incidence of NAEH in our centers since 2019, in the absence of adenoviral infection, indicates other potential triggers of similar NAEH cases. IMPACT AND IMPLICATIONS: As the current epidemic of severe acute non-A-E-hepatitis cases in children highlights our limited understanding in the field, we aim to describe current cases, characterizing the presentation over time, and defining similarities and discrepancies before and during the COVID-19 pandemic. Our data show a rising incidence of non-A-E-hepatitis cases since the beginning of the COVID-19 pandemic. These cases were not associated with adenoviral infections, suggesting that the recently described accumulation of adenovirus infections in relationship to hepatitis is a new trigger for a known phenomenon, rather than a new disease entity. Therefore, the role of protective isolation and subsequent lack of contact with trivial infections in children during the pandemic should be the subject of further examinations. We expect our data to contribute to a better understanding of severe acute hepatitis in childhood, increased vigilance for this potentially lethal disease beyond the current epidemic, and ultimately improved clinical diagnosis and care.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Leiskau C, Tsaka S, Meyer-Ruhnke L, et al. Acute severe non-A-E-hepatitis of unknown origin in children - A 30-year retrospective observational study from north-west Germany. J Hepatol. 2022. PMID: 36572350. doi:10.1016/j.jhep.2022.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。